Drug Name |
Daunorubicin hydrochloride |
Drug ID |
BADD_D00592 |
Description |
A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of leukemia and other neoplasms. |
Indications and Usage |
For remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
L01DB02 |
DrugBank ID |
DB00694
|
KEGG ID |
D01264
|
MeSH ID |
D003630
|
PubChem ID |
62770
|
TTD Drug ID |
D01XWG
|
NDC Product Code |
0143-9551; 42658-019; 58623-0046; 42658-021; 17337-0067; 0703-5233; 53183-1447; 0143-9550 |
Synonyms |
Daunorubicin | Daunomycin | Rubomycin | Dauno-Rubidomycine | Dauno Rubidomycine | Rubidomycin | Daunoblastin | Daunoblastine | NSC-82151 | NSC 82151 | NSC82151 | Cerubidine | Daunorubicin Hydrochloride | Hydrochloride, Daunorubicin |